ASCO® 2026 Highlights: Presenter Vignette – Hannah Kenny
Hannah Kenny
MD
Thomas Jefferson University Hospital
9515
A phase II study of neoadjuvant cemiplimab in hedgehog inhibitor (HHI)–naive basal cell carcinoma of the head and neck.